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ABSTRACT 25 
Susceptibility or resistance to prion infection in humans and animals depends on 26 
single prion protein (PrP) amino acid substitutions in the host, but the agent’s 27 
modulating role has not been well investigated. Compared to disease incubation 28 
times in wild type homozygous ARQ/ARQ sheep, scrapie susceptibility is reduced to 29 
near resistance in ARR/ARR animals while it is strongly enhanced in VRQ/VRQ 30 
carriers. Heterozygous ARR/VRQ animals exhibit delayed incubation periods. In BSE 31 
infection the polymorphism effect is quite different, though the ARR allotype remains 32 
the least susceptible. In this study, PrP allotype composition in protease resistant 33 
prion protein (PrPres) from brain of heterozygous ARR/VRQ scrapie infected sheep 34 
was compared with that of BSE infected sheep with similar genotype. The triplex-35 
Western blotting technique was used to estimate the two allotype PrP fractions in 36 
PrPres material from BSE infected ARR/VRQ sheep. PrPres in BSE contained 37 
equimolar amounts of VRQ- and ARR-PrP which contrasts with the excess (>95%) 38 
VRQ-PrP fraction found in scrapie. This is evidence that TSE agent properties alone, 39 
perhaps structural aspects of prions (such as PrP amino acid sequence variants and 40 
PrP conformational state) determine the polymorphic dependence of the PrPSc 41 
accumulation process in prion formation as well as the disease associated 42 
phenotypic expressions in the host. 43 
  44 
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IMPORTANCE 45 
Transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative and 46 
transmissible diseases caused by prions. Amino acid sequence variants of the prion 47 
protein (PrP) determine transmissibility in the hosts as known for classical scrapie in 48 
sheep. Each individual produces a separate PrP molecule from its two PrP gene 49 
copies. Heterozygous scrapie infected sheep that produce two PrP variants 50 
associated with opposite scrapie susceptibility (136V-PrP, high; 171R-PrP, very low) 51 
contain in their prion material over 95% of the 136V PrP variant. However, when 52 
infected with prions from cattle (BSE), both PrP variants occur in equal ratios. This 53 
shows that the infecting prion-type determines the accumulating PrP variant ratio in 54 
the heterozygous host. While the host’s PrP is considered a determining factor, these 55 
results emphasize that prion structure plays a role during host infection and that PrP 56 
variant involvement in prions of heterozygous carriers is a critical field for 57 
understanding prion formation.  58 
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INTRODUCTION 59 
Transmissible spongiform encephalopathies (TSEs) or prion diseases are fatal 60 
neurological diseases occurring in some mammalian species including man. The 61 
TSE agent or prion is characterised by the pivotal role of the host prion protein (PrP) 62 
that in disease appears aggregated and structurally abnormal, and is named PrPSc. 63 
Sc refers to scrapie in small ruminants which was recognized in the 18th century in 64 
Spanish Merino sheep (1). In healthy situations PrP is a cellular membrane protein 65 
(PrPC) and fully susceptible to proteases, while its PrPSc isoform is partially resistant 66 
to digestion with proteinase K (PK) usually leading to an N-terminally shortened 67 
protein called PrPres and contains infectivity (2-4).  68 
From many studies it is obvious that TSEs occur in distinct phenotypic forms that are 69 
recognized as TSE- or prion disease-types such as classical scrapie in sheep and 70 
goat, Creutzfeldt-Jakob disease in humans, chronic wasting disease in cervids and 71 
bovine spongiform encephalopathy (BSE) encephalopathy cattle (5-15). In the 72 
experimental situation these can be considered as strains when sub-passaged to 73 
homogeneity in rodent bioassays (16-20). Susceptibility (and resistance) to animal 74 
and human prion diseases, either in infectious or spontaneous conditions, is 75 
dependent on single amino acid substitutions in the host’s PrP sequence. In most 76 
species such substitutions occur as naturally occurring polymorphisms (7, 10, 21-24). 77 
In sheep two PrP polymorphisms in the PrP sequence - V136 and R1711 - provide 78 
respectively a high and very low susceptibility to natural scrapie compared to the 79 
homozygous wild type variants A136 and Q171. Other variants also influence 80 
susceptibility for example H154 (13, 24-30). Altogether, this has led to policies for 81 
                                                 
1 amino acids are indicated by single-letter code as used by the IUPAC-IUB Joint Commission 
on Biochemical Nomenclature (JCBN); A=alanine, Q=glutamine, R=arginine, V=valine, 
H=histidine. 
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eradication of scrapie in sheep breeds focused on codons 136, 154 and 171, in 82 
which the different alleles have the respective nomenclature: ARQ (the wild type), 83 
VRQ, AHQ, and ARR (31, 32). The codon 136 and 171 variants when both occur in 84 
heterozygous sheep are indicated with genotype code ARR/VRQ, while homozygous 85 
sheep could have genotype ARQ/ARQ (the wild type), ARR/ARR or VRQ/VRQ (7).  86 
In a previous study we reported that in scrapie infected ARR/VRQ sheep the 87 
VRQ-PrP in PrPres was highly overrepresented with 91-100% VRQ-PrP product (33, 88 
34). Yet the expression levels of the PrPC alleles in heterozygous animals are 89 
considered equal (34, 35) which means that during PrPSc formation in ARR/VRQ 90 
scrapie infected animals there occurs a selective incorporation of the VRQ-PrP 91 
allotype. In vitro assays confirm the relatively high - but not absolute - resistance to 92 
conversion of ARR-PrP when subjected to scrapie or BSE prions (12, 15, 26, 36). 93 
This special property of the ARR-PrP allotype is confirmed in in vivo intracerebral 94 
BSE challenge (i.c.) conditions, but the VRQ-PrP allotype in contrast to its strong link 95 
to susceptibility to scrapie appeared in VRQ/VRQ sheep to confer far more 96 
resistance to BSE than that found in ARQ/ARQ sheep (37).  97 
In this paper we investigated whether the level of the VRQ-PrP allotype in PrPres from 98 
ARR/VRQ BSE-infected i.c. sheep generated by Houston et al. (37) would be 99 
comparably high to that found in the same genotype of sheep with natural scrapie. 100 
This was accomplished by comparing brain PrPres in scrapie and BSE infected 101 
ARR/VRQ sheep. A previously developed robust triplex Western blot method (38, 39) 102 
was used to quantitatively estimate PrP concentrations. In this technique the Q171-103 
PrP fraction (VRQ, ARQ) can be quantitatively estimated using a mixture of two 104 
antibodies on the same blot membrane of which one antibody (SAF84) only 105 
recognizes the VRQ fraction, while the other binds equally well both VRQ-PrP and 106 
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ARR-PrP. The outcome yielded a clear-cut difference in VRQ content deposited in 107 
the prions of these two different  TSE types. This new information is special since it 108 
reports on PrP allotype expression for two separate prion types from a mammalian 109 
species (sheep) heterozygous for two non-wild type PrP alleles differing widely in 110 
their effect on susceptibility/resistance to prion infection. 111 
  112 
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MATERIALS AND METHODS  113 
Sheep brain and antibodies 114 
Brain tissues were available from ARR/VRQ, VRQ/VRQ, ARQ/ARQ and ARR/ARR 115 
sheep clinically affected following intracerebral challenge with cattle BSE, and from 116 
naturally infected scrapie sheep with genotypes ARR/VRQ, VRQ/VRQ, ARQ/ARQ, 117 
and ARQ/VRQ detected in active surveillance monitoring. The details of the different 118 
groups of sheep are presented in Table I. The BSE and classical scrapie diagnosis 119 
was carried out on brain stem tissue of each animal by immunohistochemistry and by 120 
Western blotting (40-42).  121 
Monoclonal antibodies used were L42, Sha31 and SAF84 (43-45) with respective 122 
linear ovine PrP epitope sequences 148-153, 148-155 and 166-172 as determined 123 
using Pepscan epitope mapping technology (46), and IgG class numbers a2, 1 and 124 
b2. Though L42 and Sha31 share nearly the same linear epitope, they were raised 125 
with very different antigens being respectively a linear peptide derived from ovine PrP 126 
and PK digested non-denatured scrapie associated fibrils from Syrian hamsters. 127 
Molecular Probes™ Zenon® Alexa Fluor® mouse labelling kits for mouse IgG1 (Alexa 128 
647), IgG2a (Alexa 647) and IgG2b (Alexa 488) were from ThermoFisher. For 129 
molecular mass estimation a Pre-Stained SeeBlue Standards kit (LC5625; 130 
ThermoFisher) was used. Ovine recombinant ARQ-PrP was a gift from Human 131 
Rezaei (INRA, Jouy-en Jozas France) (47). 132 
 133 
PrPres preparation and quantification of allotype expression with mixed 134 
antibody Western blotting 135 
PrPres was prepared from ten percent (wt/vol) brain stem homogenates prepared in 136 
lysis buffer, digested with PK at 37°C, and further partially purified by precipitation 137 
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with 1-propanol as described (38). Sodium dodecyl sulphate poly-acrylamide gel 138 
electrophoresis of denatured samples in loading buffer (with lithium-dodecyl sulphate 139 
and β-mercaptoethanol) was performed in 17 wells gels (33). Detection of PrPres on 140 
blot membranes was carried out in our triplex Western blotting system, but for this 141 
study a mixture of only two primary antibodies instead of three was used. The 142 
antibodies were labelled with Zenon Alexa Fluor kits before application on the blot. 143 
Immunochemical quantification of PrPres was subsequently performed by fluorimetric 144 
detection monitored in a three laser beam imager (Typhoon Trio variable-mode 145 
imager, Amersham Biosciences) (38). For estimation of the ARR-  and VRQ-PrP 146 
fraction in PrPres, a mixture of two antibodies was applied of which one (SAF84) will 147 
bind only if the 171Q polymorphism is present (VRQ-PrP or ARQ-PrP) while the other 148 
is equally well binding to both VRQ-, ARQ- and ARR-PrP (33, 38, 39). Two different 149 
mixtures with SAF84 were used: SAF84 with L42 (L42/SAF84 combination) and 150 
SAF84 with Sha31 (Sha31/SAF84 combination). SAF84 detection was carried out 151 
with a Zenon labelling Alexa 488 kit, and L42 or Sha31 with a Zenon labelling Alexa 152 
647 kit (see above for kit specifications). The VRQ-PrP and ARQ-PrP fractions in 153 
PrPres samples were calculated as follows (33, 38, 39). When using the SAF84/L42 154 
antibody combination the fraction of the 171Q-PrP (the VRQ- of ARQ-PrP levels) 155 
product in scrapie or BSE was obtained by applying the formula Fr(171Q-PrP) = 156 
ratiox/ratioQ/Q where ratiox is the SAF84/L42 ratio of an unknown sample and ratioQ/Q 157 
is the SAF84/L42 ratio determined for Q/Q homozygous material, which was an 158 
average of measurements of the different scrapie (n=10) or BSE (n=8) Q/Q samples; 159 
likewise, the fraction of 171R-PrP product (the ARR-PrP level) could be deduced 160 
from the formula (ratioQ/Q – ratiox)/ratioQ/Q. For the SAF84/Sha31 combination the 161 
same formulas were applied but replacing the L42 values for those of Sha31. 162 
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The validity of the approach was confirmed by mixing in loading buffer samples from 163 
a VRQ/VRQ and an ARR/ARR sheep both infected with BSE in volume ratios 9/1, 164 
8.5/1.5, 8/2, 7.5/2.5 7/3, 6/4, 5/5, 4/6, 3/7, 2/8 and 1/9 (for both antibody 165 
combinations). To exclude the possibility that the outcomes were influenced by the 166 
concentration of the PrPres signal, a further check was performed by calculating the 167 
PrPres signal per sample in ng PrP as observed from the L42 and Sha31 detection 168 
using the recombinant PrP signal as a reference of which 15 ng was run in a lane of 169 
each gel. 170 
  171 
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RESULTS  172 
PrPres samples from sheep homozygous for the 171Q codon allele (genotypes 173 
VRQ/VRQ and ARQ/ARQ) exhibited full reactivity with the antibodies L42 and SAF84 174 
in both BSE and scrapie infected animals (Fig. 1a, respectively lanes 3-5 and 10-11). 175 
As expected, the PrPres from ARR/ARR BSE infected sheep reacted with antibody 176 
L42 but not at all with SAF84 (Fig. 1a, lanes 15-16). Scrapie infected ARR/ARR 177 
sheep were not available since these animals remained TSE negative throughout 178 
their experimental life time indicative for the high scrapie resistance contributed by 179 
the 171R codon (>2000 days, data to be published by Houston and Hunter). The 180 
analyses from the heterozygous ARR/VRQ sheep with scrapie and BSE yielded 181 
contrasting results in that the staining with SAF84 relative to L42 on scrapie infected 182 
sheep samples were very similar to each other while that of SAF84 on the BSE 183 
samples was reduced. Similar results were observed when using the SAF84/Sha31 184 
antibody duplex combination (Figure 1b). A further calculation of the fraction of VRQ-185 
PrP in the PrPres samples from the heterozygous animals using the SAF84/L42 186 
combination yielded for scrapie infected ARR/VRQ sheep a VRQ-PrP fraction 187 
Fr.(171Q-PrP) of 1.01 ± 0.07 (average ± standard deviation; n=7, Fig.1b). This 188 
compared fairly well with previous estimations using 2D gel electrophoresis on 189 
isolated PrPres fragments and two different Western blotting techniques (an 190 
enzymatically enhanced chemo-luminescence immunodetection method and a 191 
triplex-WB based fluorescence immunolabelling method) (33). It further implied that 192 
the ARR-PrP fraction varied between different ARR/VRQ sheep derived samples 193 
from 0 to only 0.1. In contrast, for BSE infected ARR/VRQ sheep, the VRQ-PrP 194 
fraction was 0.53 ± 0.05 (n=4) indicating that PrPres of the BSE infected ARR/VRQ 195 
animals contained a nearly equal amounts of both VRQ-PrP and ARR-PrP allotype 196 
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product. Similar values were obtained when tested with the SAF84/Sha31 197 
combination (Figure 1b). 198 
The validity of this approach was confirmed by mixing a VRQ/VRQ with an ARR/ARR 199 
BSE sample in loading buffer in different proportions from 9/1 to 1/9. The output 200 
versus input curves for VRQ-PrP fraction of PrPres were concave but approached 201 
linearity rather well when using either the SAF84/L42 or the SAF84/Sha31 antibody 202 
combination (Fig. 2). The final data shown in Figure 1b represent adjusted values 203 
based on these concave curves. Finally, an effect of PrPres concentration in the tissue 204 
digest on the outcomes was estimated. The regression curves obtained for scrapie 205 
and BSE samples were approaching a horizontal line, pointing to negligible effects 206 
from the PrPres concentration on the Fr(171Q-PrP) values (Fig. 3). For all individual 207 
and overall sample data, the outcomes with the SAF84/L42 and SAF84/Sha31 208 
antibody combinations were very comparable. Also, the current scrapie data confirm 209 
our previous results from ARR/VRQ scrapie infected sheep as determined in different 210 
ways and prove the quantitative value of the current immunochemical Western 211 
blotting methodology used (33).  212 
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DISCUSSION 213 
The analyses of the PrP-allotype composition of prion material in heterozygous 214 
ARR/VRQ sheep yielded for BSE infected sheep a VRQ-PrP fraction approaching 215 
0.5. This contrasted to the fraction determined in scrapie infected sheep where the 216 
VRQ-PrP fraction approximated 1, thus representing nearly all of the PrPres mass. 217 
Since in the ARR/VRQ scrapie PrPres only one allotype is found while both alleles 218 
because of diploidy can and do express PrP (34, 48), it is surprising that the ARR-219 
PrP fraction in the PrPres material of the scrapie cases is nearly zero. This is in 220 
contrast to the ~50% ARR-PrP fraction in ARR/VRQ BSE PrPres mass.  This wide 221 
difference in VRQ-PrP and ARR-PrP content in the prion material of these sheep with 222 
scrapie and BSE infection is unique for three reasons. Firstly, two different acquired 223 
(infectious) conditions of prion disease were studied in these animals. Secondly, 224 
individual animals carrying two non-wild type PrP alleles with very contrasting 225 
TSE-type susceptibilities were investigated - while on the one hand the VRQ-PrP 226 
makes them highly susceptible to scrapie, on the other hand the ARR-PrP makes 227 
them resistant to both BSE and scrapie., Thirdly, the study was performed on tissues 228 
obtained from infected animals, thus the prions studied are products of in vivo 229 
conditions. These data from heterozygous animals carrying two different 230 
TSEs - scrapie or BSE - confirm in vitro conversion data that a certain PrP 231 
polymorphism of the “host” can be less prone to conversion to PrPSc than another 232 
(15, 26). Or as alternative to the species barrier concept, on infection with scrapie, 233 
only ARR-PrP forms a polymorphism barrier whereas with primary infection with BSE 234 
both ARR- and VRQ-PrP contribute to this barrier. Importantly, these new data also 235 
strongly support the concept that type (or strain) of the infecting agent itself has an 236 
influence on this conversion event.  237 
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 238 
The role a certain prion type plays in susceptibility and resistance of the sheep host is 239 
strikingly reflected in in vivo situations as will be exemplified with three different TSE 240 
types. With BSE infection, ARR/ARR and VRQ/VRQ sheep have long incubation 241 
times to clinical disease following intracerebral challenge at respectively >1400 days 242 
and >1000 days, compared to that in the wild type ARQ/ARQ sheep (around 600 243 
days) (N. Hunter and F. Houston, personal communication). With classical scrapie 244 
infection with the agent derived from VRQ-rich sheep flocks, ARR/ARR sheep are 245 
nearly fully resistant to challenge whereas VRQ/VRQ sheep with scrapie have very 246 
short incubation times (180-720 days), and the wild type (ARQ/ARQ) sheep have 247 
intermediate incubation times (14, 27, 36, 37, 40, 49-51). Interestingly with 248 
atypical/Nor98 scrapie, a prion disease that is non-spreading and maybe of 249 
spontaneous origin, VRQ/VRQ animals appear highly insensitive based on genotype 250 
frequency, while ARR/ARR sheep can be affected but are less frequent than 251 
ARQ/ARQ sheep with this scrapie type (Table II) (52). Though the susceptibilities to 252 
prion diseases may also be influenced by route of infection, prevailing flock 253 
PrP-polymorphism, extent of involvement of the lympho-reticular system and other 254 
pathogenic aspects, the above mutual differences in susceptibilities are relatively 255 
consistent. A breed effect between the Cheviot and Texel sheep used in this study 256 
can not be excluded as another factor for the potential difference in allotype ratio 257 
between BSE and scrapie infected ARR/VRQ animals but susceptibilities to TSE 258 
within a breed (in casu Romanovs) are expected to be largely independent of 259 
polygenic effects and this may also apply to between breed effects (14, 53). 260 
Therefore the allotype PrP composition in prion material as found in our results is 261 
reflecting the effect of the type of TSE or prion agent rather than variation in the host. 262 
111221_1_art_file_1840880_nw78nv.docx 
14 
 
 263 
In studies performed on TSE infections other than in sheep, some results have been 264 
obtained in bank voles. One polymorphism has been described which if present in 265 
109M/I animals leads to 20-30% differences in incubation times for the heterozygous 266 
animals compared to the wild type carriers after intracerebral infection with sheep or 267 
goat scrapie, but equal incubation times after infection with mouse scrapie strain 268 
139A (23, 54). In these models deposition of both wild type and non-wild type PrP 269 
allotypes were observed in significant amounts pointing to equal allotype levels in the 270 
prions. This equal deposition of both allotype PrPs in heterozygous bank voles might 271 
indicate that incubation times alone are not sufficiently indicative of a great difference 272 
in convertibility of PrPC to PrPSc and therefore leads to 100% attack rates. Thus, the 273 
situation in these bank vole experiments is different from that in ARR/VRQ sheep 274 
where two non-wild type PrP allotypes have been studied, each of them with a 275 
proven influence on susceptibility and PrPC to PrPSc convertibility. 276 
 277 
In contrast to infectious conditions, in inherited human TSEs, the patients carry a PrP 278 
gene linked predisposition to develop disease by a mutation in the coding region of 279 
the PRNP gene. The patients are nearly always heterozygous (55, 56). Depending 280 
on the polymorphism the non-wild type variant is frequently the dominant PrP variant 281 
present in the PK resistant or detergent insoluble PrPSc material, but in some 282 
instances wild type and non-wild type PrP are both present in significant amounts 283 
(55, 57-63). The PrP allotype prevalence in the deposited prion PrP material is 284 
supposed to depend on the position and nature of the amino acid in the PrP 285 
sequence. In these spontaneous prion diseases, PrPC can be considered to be the 286 
main host factor determining the PrP allotype ratio of the prion material. However, the 287 
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role of non-PrP host factors should also be taken into consideration (64). In infectious 288 
conditions such as those studied in animals, the agent itself can have an equally 289 
important role to that of host PrP and non-PrP host factors. Probably, binding of 290 
PrPSc to PrPC (at least for sheep PrP) does not discriminate between different 291 
polymorphic PrP variants, while the PrPC to PrPSc conversion efficiency clearly is 292 
related to PrP linked genotype dependent susceptibilities as was shown for sheep 293 
prions (12, 15, 27, 36, 65).  294 
 295 
The example of possibly different allotype compositions in prion material between two 296 
TSE types - scrapie and BSE - as exemplified in the ARR/VRQ sheep of this study is 297 
a novel finding for in vivo situations and confirm the in vitro studies that show that 298 
different TSE types have a different PrP polymorphism variant preference in the PrPC 299 
to PrPSc conversion (13, 14, 36). It also shows that, in disease, the prion type can 300 
determine the ability of certain host PrP allotype sequence-variants to be converted 301 
from PrPC to PrPSc. The critical issue of how the conversion process works and 302 
whether other factors than only PrP amino acid sequence of the host can influence it 303 
is still uncertain. The species source from which the infection is derived is one 304 
determinant (36), as in our case the BSE material to infect the sheep is from bovine 305 
origin. Bovine PrP differs from sheep PrP in having an extra octarepeat in the PrP N-306 
terminus and six further amino acid codon differences (sheep PrP codons 98, 100, 307 
146, 158, 189 and 208) (48, 66). Further structural differences in the folding of the 308 
prions of BSE and different scrapie types  might well have a role in susceptibility of 309 
the host, as has been hypothesized in sheep challenge experiments with BSE, 310 
CH1641 scrapie and SSBP1 scrapie (13). Whether a non-PrP factor in the agent 311 
could play a role remains to be investigated. However considering the major role of 312 
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PrPSc structure in TSEs, our data suggest that further studies on PrP allotype 313 
heterozygosity in agent and host are needed in order to understand the factors 314 
determining the fate of prion diseases.  315 
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FIGURE LEGENDS 573 
Figure 1: PrP allotype fraction estimates in PrPres from brain of PrP scrapie and BSE 574 
infected sheep with different PRNP genotypes. a, Western blot of scrapie and BSE 575 
PrPres samples of infected sheep with heterozygous and homozygous genotypes as 576 
tested with the L42-SAF84 antibody combination. Lanes: 1 and 8, rec-ovinePrP; 2 577 
and 9, molecular mass standards; 3-5, VRQ/VRQ sheep with scrapie; 6-7 ARR/VRQ 578 
sheep with scrapie; 10-12, VRQ/VRQ sheep with BSE; 13-14, ARR/VRQ with BSE; 579 
15-16 ARR/ARR sheep with BSE. Blotting procedures followed the triplex WB 580 
method as described (38, 39). Tissue equivalents per each brain sample applied 581 
were 0.5 mg per lane. b, VRQ- or ARQ-PrP and ARR-PrP allotype fractions per 582 
genotype group of sheep with scrapie or BSE. Genotypes are given for PrP-amino 583 
acid residue positions 136, 154 and 171; XRQ means combined data from either 584 
three (scrapie: ARQ/ARQ, VRQ/VRQ, ARQ/VRQ) or two genotypes (BSE: 585 
ARQ/ARQ, VRQ/VRQ) respectively. The results of the two antibody combinations – 586 
SAF84/L42 and SAF84/Sha31 - are presented and appeared very similar. Bar fillings: 587 
black represent the VRQ- and/or ARQ-PrP fraction, open the ARR-PrP fraction. The 588 
number within the bars reflect the average XRQ-PrP fraction, and vertical lines the 589 
standard deviation of the XRQ fraction. Individual sample numbers are given as n=#. 590 
 591 
Figure 2: Probing the VRQ-PrP allotype level between input and calculated output 592 
level in PrPres samples in dose response mixing experiments. See Methods section 593 
for design of experiment. For both duplex antibody combinations similar concave 594 
curves were obtained. These  hollow curves were used for calculation of the final 595 
data in Figure 1b. Thus a sample with an output value of 20, 40, 60 or 80% VRQ-PrP 596 
allotype, yielded in case of the SAF84/L42 combination respectively 30, 55, 72, and 597 
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87% and for the SAF84/Sha31 29, 51, 67 and 86% VRQ-PrP. The inset presents the 598 
values of the calculated regression lines derived from the data points. 599 
 600 
Fig. 3: Relation between PrPres concentration and VRQ-PrP level of ARR/VRQ sheep 601 
brain. For individual samples from ARR/VRQ sheep the PrP concentration in the 602 
samples was calculated using recPrP as standard in both blots probed with the 603 
SAF84/L42 (closed circles) and SAF84/Sha31 (open triangles) antibody combination 604 
(see Methods section). The VRQ-PrP levels were in all individual samples around 1 605 
in the scrapie samples and 0.5 in the BSE samples. The linear regression formulae 606 
for the two antibody combinations data point to near horizontal curves, indicative for 607 
absence of a concentration effect on the Fr(171Q-VRQ) values in the triplex-WB 608 
methodology used. 609 
  610 
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Table I: Sheep genotypes, TSE type tissues, laboratory origin and breeda 611 
 612 
TSE genotype # of cases lab source breed 
i.c. BSEb 
ARR/VRQ 4 Roslin-UEDINc Cheviot 
VRQ/VRQ 5 Roslin-UEDINc Cheviot 
ARQ/ARQ 3 INRA-Tours2nd Suffolk 
ARR/ARR 3 INRA-Tours Poll Dorset 
natural scrapie 
ARR/VRQ 7 CVI-WageningenUR Texel-cross breed
VRQ/VRQ 2 CVI-WageningenUR Texel-cross breed
ARQ/ARQ 4 CVI-WageningenUR Texel-cross breed
ARQ/VRQ 4 CVI-WageningenUR Texel-cross breed
a Scrapie brain stem tissues were from natural field cases, BSE brain stem or 613 
midbrain tissues were either from intracerebral infections with bovine BSE in 614 
VRQ/VRQ, ARR/VRQ and ARR/ARR sheep, or in the case of superscript 2nd by i.c. 615 
passage from bovine BSE infected ARQ/ARQ sheep to ARQ/ARQ sheep. 616 
b i.c., intracerebral infection. 617 
c Publication of detailed study in preparation (Houston and Hunter). 618 
 619 
 620 
621 
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Table II. Susceptibility dependence on TSE/prion type and host PrP 622 
polymorphisma. 623 
 624 
disease type 
PrP allotype susceptible to acquire 
disease type 
most medium least 
BSE wt V136 R171 
classical scrapie V136 wt R171 
atypical/Nor98 scrapie wt R171 V136 
a Susceptibility is presented in a qualitative way for the single amino acid allotype. 625 
Wild type represents the A136R154Q171 allele. Data about BSE are from experimental 626 
infections, classical scrapie from natural and experimental infections, atypical/Nor98 627 
scrapie from active monitoring in a number of European countries. 628 
 629 
 630 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
L42
SAF84
a 
b 


